Source: Eur Respir Monogr 2010; 50: 150-173
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M.R. Bonsignore, S. Battaglia, A. Zito, C. Lombardi, G. Parati. Sleep apnoea and systemic hypertension. Eur Respir Monogr 2010; 50: 150-173

Member's Comments

No comment yet.

Related content which might interest you: Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007 Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Sleep-disordered breathing and hormones Source: Eur Respir J 2003; 22: 161-172 Year: 2003 Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Can we correct the cardiovascular risks with treatment? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 682s Year: 2006 The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 Outcomes of OSA and indications for different therapies Source: Eur Respir Mon 2010; 50: 225-243 Year: 2010